• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

压力超负荷与主动脉瓣狭窄患者心脏中肌钙蛋白I和肌球蛋白结合蛋白C磷酸化水平降低有关。

Pressure Overload Is Associated With Low Levels of Troponin I and Myosin Binding Protein C Phosphorylation in the Hearts of Patients With Aortic Stenosis.

作者信息

Copeland O'neal, Messer Andrew, Jabbour Andrew, Poggesi Corrado, Prasad Sanjay, Marston Steven

机构信息

Imperial College London, London, United Kingdom.

Royal Brompton Hospital, and Imperial College London, London, United Kingdom.

出版信息

Front Physiol. 2020 Mar 19;11:241. doi: 10.3389/fphys.2020.00241. eCollection 2020.

DOI:10.3389/fphys.2020.00241
PMID:32265736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7096377/
Abstract

In previous studies of septal heart muscle from HCM patients with hypertrophic obstructive cardiomyopathy (HOCM, LVOT gradient 50-120 mmHg) we found that the level of phosphorylation of troponin I (TnI) and myosin binding protein C (MyBP-C) was extremely low yet samples from hearts with HCM or DCM mutations that did not have pressure overload were similar to donor heart controls. We therefore investigated heart muscle samples taken from patients undergoing valve replacement for aortic stenosis, since they have pressure overload that is unrelated to inherited cardiomyopathy. Thirteen muscle samples from septum and from free wall were analyzed (LVOT gradients 30-100 mmHg) The levels of TnI and MyBP-C phosphorylation were determined in muscle myofibrils by separating phosphospecies using phosphate affinity SDS-PAGE and detecting with TnI and MyBP-C specific antibodies. TnI was predominantly monophosphorylated and total phosphorylation was 0.85 ± 0.03 molsPi/mol TnI. This phosphorylation level was significantly different ( < 0.0001) from both donor heart TnI (1.6 ± 0.06 molsPi/mol TnI) and HOCM heart TnI (0.19 ± 0.04 molsPi/mol TnI). MyBP-C is phosphorylated at up to four sites. In donor heart the 4P and 3P species predominate but in the pressure overload samples the 4P species was much reduced and 3P and 1P species predominated. Total phosphorylation was 2.0 ± 0.2 molsPi/mol MyBP-C ( = 8) compared with 3.4 ± 0.07 ( = 21) in donor heart and 1.1 ± 0.1 ( = 10) in HOCM heart. We conclude that pressure overload may be associated with substantial dephosphorylation of troponin I and MyBP-C.

摘要

在先前对肥厚性梗阻性心肌病(HOCM,左心室流出道梯度为50 - 120 mmHg)的肥厚型心肌病(HCM)患者的间隔心肌研究中,我们发现肌钙蛋白I(TnI)和肌球蛋白结合蛋白C(MyBP - C)的磷酸化水平极低,但来自没有压力超负荷的HCM或DCM突变心脏的样本与供体心脏对照相似。因此,我们研究了因主动脉瓣狭窄接受瓣膜置换术患者的心肌样本,因为他们存在与遗传性心肌病无关的压力超负荷。分析了13个来自间隔和游离壁的心肌样本(左心室流出道梯度为30 - 100 mmHg)。通过使用磷酸盐亲和SDS - PAGE分离磷酸化形式并用TnI和MyBP - C特异性抗体进行检测,测定肌原纤维中TnI和MyBP - C的磷酸化水平。TnI主要为单磷酸化,总磷酸化水平为0.85±0.03 molPi/mol TnI。该磷酸化水平与供体心脏TnI(1.6±0.06 molPi/mol TnI)和HOCM心脏TnI(0.19±0.04 molPi/mol TnI)均有显著差异(<0.0001)。MyBP - C最多在四个位点磷酸化。在供体心脏中,4P和3P形式占主导,但在压力超负荷样本中,4P形式大幅减少,3P和1P形式占主导。总磷酸化水平为2.0±0.2 molPi/mol MyBP - C(n = 8),相比之下,供体心脏为3.4±0.07(n = 21),HOCM心脏为1.1±0.1(n = 10)。我们得出结论,压力超负荷可能与肌钙蛋白I和MyBP - C的大量去磷酸化有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/7096377/6ec8557ac440/fphys-11-00241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/7096377/3d35535d8332/fphys-11-00241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/7096377/6ec8557ac440/fphys-11-00241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/7096377/3d35535d8332/fphys-11-00241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b232/7096377/6ec8557ac440/fphys-11-00241-g002.jpg

相似文献

1
Pressure Overload Is Associated With Low Levels of Troponin I and Myosin Binding Protein C Phosphorylation in the Hearts of Patients With Aortic Stenosis.压力超负荷与主动脉瓣狭窄患者心脏中肌钙蛋白I和肌球蛋白结合蛋白C磷酸化水平降低有关。
Front Physiol. 2020 Mar 19;11:241. doi: 10.3389/fphys.2020.00241. eCollection 2020.
2
The use of phosphate-affinity SDS-PAGE to measure the cardiac troponin I phosphorylation site distribution in human heart muscle.利用磷酸化 SDS-PAGE 测定人心肌肌钙蛋白 I 磷酸化位点分布。
Proteomics Clin Appl. 2009 Dec;3(12):1371-82. doi: 10.1002/prca.200900071. Epub 2009 Oct 13.
3
Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.由于肌钙蛋白 T 的异常,肥厚型梗阻性心肌病中的肌原纤维 Ca(2+) 敏感性与肌钙蛋白 I 磷酸化脱耦联。
Cardiovasc Res. 2013 Mar 1;97(3):500-8. doi: 10.1093/cvr/cvs322. Epub 2012 Oct 24.
4
The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function.心肌肌球蛋白结合蛋白C和肌钙蛋白I磷酸化对体内心脏功能β-肾上腺素能增强作用的贡献。
J Physiol. 2016 Feb 1;594(3):669-86. doi: 10.1113/JP270959.
5
Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle.人心肌肌球蛋白结合蛋白-C磷酸化分析。
J Mol Cell Cardiol. 2010 Dec;49(6):1003-11. doi: 10.1016/j.yjmcc.2010.09.007. Epub 2010 Sep 17.
6
Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle.正常、肥厚和衰竭的人类心肌中肌球蛋白结合蛋白C的磷酸化
J Mol Cell Cardiol. 2008 Aug;45(2):209-16. doi: 10.1016/j.yjmcc.2008.05.020. Epub 2008 Jun 4.
7
MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.MYBPC3 截断突变增强人类肥厚型心肌病中的肌球蛋白收缩力学。
J Mol Cell Cardiol. 2019 Feb;127:165-173. doi: 10.1016/j.yjmcc.2018.12.003. Epub 2018 Dec 11.
8
Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation.与扩张型心肌病相关的肌联蛋白截断突变改变了其依赖长度的激活及其通过磷酸化的调节。
Cardiovasc Res. 2022 Jan 7;118(1):241-253. doi: 10.1093/cvr/cvaa316.
9
The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin I.导致扩张型心肌病的突变ACTC E361G存在于心肌肌原纤维中,它特异性地消除了肌钙蛋白I磷酸化对Ca(2+)调节的调控作用。
Biophys J. 2014 Nov 18;107(10):2369-80. doi: 10.1016/j.bpj.2014.10.024.
10
Uncoupling of myofilament Ca2+ sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate.通过突变使肌丝钙敏感性与肌钙蛋白I磷酸化解偶联的现象可被表没食子儿茶素-3-没食子酸酯逆转。
Cardiovasc Res. 2015 Oct 1;108(1):99-110. doi: 10.1093/cvr/cvv181. Epub 2015 Jun 24.

引用本文的文献

1
Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics.不同肥厚型心肌病基因型导致的相似肌节蛋白构象表型可通过自上而下的蛋白质组学技术揭示。
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24691-24700. doi: 10.1073/pnas.2006764117. Epub 2020 Sep 23.
2
Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca(2+)-sensitivity in the pathogenesis of cardiomyopathy.研究肌钙蛋白 I 磷酸化与肌球蛋白纤维 Ca(2+)敏感性变化解偶联在心肌病发病机制中的作用。
Front Physiol. 2014 Aug 25;5:315. doi: 10.3389/fphys.2014.00315. eCollection 2014.

本文引用的文献

1
The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM.肌钙蛋白 T 基因突变导致人类肥厚型心肌病肌小节构象改变。
J Gen Physiol. 2019 Jan 7;151(1):18-29. doi: 10.1085/jgp.201812160. Epub 2018 Dec 21.
2
Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling.心力衰竭治疗的靶点:聚焦于影响β肾上腺素能受体信号传导的G蛋白偶联受体激酶和β抑制蛋白
Front Pharmacol. 2018 Nov 27;9:1336. doi: 10.3389/fphar.2018.01336. eCollection 2018.
3
Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation.
与肥厚型心肌病相关的肌钙蛋白T突变增加了Ca(2+)敏感性,并抑制了肌钙蛋白I磷酸化对Ca(2+)敏感性的调节。
Arch Biochem Biophys. 2016 Jul 1;601:113-20. doi: 10.1016/j.abb.2016.03.027. Epub 2016 Mar 29.
4
Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca(2+)-sensitivity in the pathogenesis of cardiomyopathy.研究肌钙蛋白 I 磷酸化与肌球蛋白纤维 Ca(2+)敏感性变化解偶联在心肌病发病机制中的作用。
Front Physiol. 2014 Aug 25;5:315. doi: 10.3389/fphys.2014.00315. eCollection 2014.
5
Heart research advances using database search engines, Human Protein Atlas and the Sydney Heart Bank.利用数据库搜索引擎、人类蛋白质图谱和悉尼心脏银行推进心脏研究。
Heart Lung Circ. 2013 Oct;22(10):819-26. doi: 10.1016/j.hlc.2013.06.006. Epub 2013 Jul 13.
6
Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.家族性扩张型心肌病突变使肌钙蛋白 I 磷酸化与肌球蛋白纤维 Ca²⁺敏感性的变化解耦。
Cardiovasc Res. 2013 Jul 1;99(1):65-73. doi: 10.1093/cvr/cvt071. Epub 2013 Mar 27.
7
Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.肌节基因突变致肥厚型心肌病中受干扰的长度依赖性激活。
Circ Res. 2013 May 24;112(11):1491-505. doi: 10.1161/CIRCRESAHA.111.300436. Epub 2013 Mar 18.
8
Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.由于肌钙蛋白 T 的异常,肥厚型梗阻性心肌病中的肌原纤维 Ca(2+) 敏感性与肌钙蛋白 I 磷酸化脱耦联。
Cardiovasc Res. 2013 Mar 1;97(3):500-8. doi: 10.1093/cvr/cvs322. Epub 2012 Oct 24.
9
Treatment options in severe aortic stenosis.重度主动脉瓣狭窄的治疗选择
Circulation. 2011 Jul 19;124(3):355-9. doi: 10.1161/CIRCULATIONAHA.110.974204.
10
Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.导致人心肌肌球蛋白重链基因突变 E99K 引起人心肌和鼠心肌心尖肥厚的分子机制
J Biol Chem. 2011 Aug 5;286(31):27582-93. doi: 10.1074/jbc.M111.252320. Epub 2011 May 26.